Company intelligence / Profile preview

Jilin Province Baker Pharmaceutical

Meihekou, Jilin, China

Ownership: Private
Development stage: Other

Overview

Jilin Baker Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of anti-viral and anti-infective medications. The company is particularly recognized for its focus on treatments for chronic Hepatitis B and HIV, producing several generic and innovative small molecule drugs. Its product portfolio includes widely used antiviral agents such as Entecavir and Adefovir Dipivoxil. Jilin Baker operates large-scale manufacturing facilities in Jilin Province, adhering to Good Manufacturing Practice (GMP) standards to supply both domestic and international markets.

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

xinning tablets

Unknown

Beyond the preview

Go deeper on Jilin Province Baker Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jilin Province Baker Pharmaceutical.

Explore the full profile